Constellation Wealth Advisors’s Pfizer PFE Stock Holding History

Constellation Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$344K	Sell	11,556 -158	-1%	-$5.07K	0.04%	69
2015 Q2	$373K	Hold	11,714	–	–	0.03%	148
2015 Q1	$387K	Buy	11,714 +158	+1%	+$5.02K	0.03%	153
2014 Q4	$342K	Buy	11,556 +1,792	+18%	+$51.4K	0.03%	154
2014 Q3	$274K	Buy	9,764 +1,669	+21%	+$46.8K	0.03%	175
2014 Q2	$228K	Sell	8,095 -15,368	-65%	-$438K	0.03%	172
2014 Q1	$715K	Buy	23,463 +1,835	+8%	+$54.7K	0.07%	131
2013 Q4	$628K	Sell	21,628 -938	-4%	-$27.3K	0.06%	139
2013 Q3	$615K	Buy	22,566 +3,452	+18%	+$93.9K	0.07%	132
2013 Q2	$508K	Buy	+19,114	New	+$528K	0.06%	137

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Constellation Wealth Advisors's PFE Position: Q3 2015 in Review

Constellation Wealth Advisors reduced its Pfizer (PFE) stake by 1.3% in Q3 2015, selling an estimated $5.07K and leaving 11,556 shares worth $344K. The position accounts for 0.04% of the portfolio, ranked #69.

Constellation Wealth Advisors first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. The position peaked at $715K in Q1 2014. 1,880 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

Constellation Wealth Advisors held 11,556 shares of Pfizer worth $344K as of Q3 2015.
Constellation Wealth Advisors sold 158 Pfizer shares in Q3 2015, an estimated $5.07K.
Pfizer made up 0.04% of Constellation Wealth Advisors's portfolio in Q3 2015, its #69 holding.
Constellation Wealth Advisors first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
Constellation Wealth Advisors's Pfizer position peaked at $715K in Q1 2014.
1,880 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on Constellation Wealth Advisors's 13F filing for Q3 2015, filed 9 Nov 2015.